[1] |
Goodfield MJD, Jones SK, Veale DJ. Disabling pansclerotic morphoea of children[M]//Burns T, Breathnach S, Cox N, et al. Rook′s Textbook of Dermatology. 8th ed. Oxford: Blackwell Publishing, 2010:2494⁃2495.
|
[2] |
Diaz⁃Perez JL, Connolly SM, Winkelmann RK. Disabling pan⁃sclerotic morphea of children[J]. Arch Dermatol, 1980,116(2):169⁃173.
|
[3] |
Singh A, Singhal K, Choudhary S, et al. Adult⁃onset unilateral disabling pansclerotic morphea[J]. Indian J Dermatol, 2014,59(3):316. doi: 10.4103/0019⁃5154.131459.
|
[4] |
Maragh SH, Davis MD, Bruce AJ, et al. Disabling pansclerotic morphea: clinical presentation in two adults[J]. J Am Acad Dermatol, 2005,53(2 Suppl 1):S115⁃119. doi: 10.1016/j.jaad.2004. 10.881.
|
[5] |
Wollina U, Buslau M, Heinig B, et al. Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma[J]. Int J Low Extrem Wounds, 2007,6(4):291⁃298. doi: 10.1177/1534734607308731.
|
[6] |
Ruiz⁃Matta JM, Flores⁃Bozo LR, Dominguez⁃Cherit J. Metastatic squamous cell carcinoma in a patient with disabling pansclerotic morphea of childhood[J]. Pediatr Dermatol, 2017,34(4):e164⁃164e167. doi: 10.1111/pde.13160.
|
[7] |
Röcken M, Ghoreschi K. Disabling pansclerotic morphea of children[M]//Bolognia JL, Heymann WR, Schwarz T. Dermatology. 3rd ed. Singapore: Elsevier Limited, 2012:662⁃663.
|
[8] |
Odhav A, Hoeltzel MF, Canty K. Pansclerotic morphea with features of eosinophilic fasciitis: distinct entities or part of a continuum?[J]. Pediatr Dermatol, 2014,31(2):e42⁃47. doi: 10.1111/ pde.12279.
|
[9] |
Zulian F, Martini G, Vallongo C, et al. Methotrexate treatment in juvenile localized scleroderma: a randomized, double⁃blind, placebo⁃controlled trial[J]. Arthritis Rheum, 2011,63(7):1998⁃2006. doi: 10.1002/art.30264.
|
[10] |
Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high⁃dose corticosteroids combined with low⁃dose methotrexate in severe localized scleroderma[J]. Arch Dermatol, 2005,141(7):847⁃852. doi: 10.1001/archderm.141.7.847.
|
[11] |
Martini G, Ramanan AV, Falcini F, et al. Successful treatment of severe or methotrexate⁃resistant juvenile localized scleroderma with mycophenolate mofetil[J]. Rheumatology (Oxford), 2009,48(11):1410⁃1413. doi: 10.1093/rheumatology/kep244.
|
[12] |
Todd DJ, Askari A, Ektaish E. PUVA therapy for disabling pansclerotic morphoea of children[J]. Br J Dermatol, 1998,138(1): 201⁃202.
|
[13] |
Scharffetter⁃Kochanek K, Goldermann R, Lehmann P, et al. PUVA therapy in disabling pansclerotic morphoea of children[J]. Br J Dermatol, 1995,132(5):830⁃831.
|